Aytu BioPharma (AYTU) Competitors $2.35 +0.04 (+1.73%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.35 0.00 (0.00%) As of 08/29/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AYTU vs. PMVP, EXOZ, IGMS, ASRT, ABVC, UNCY, VNRX, APLT, OVID, and STROShould you be buying Aytu BioPharma stock or one of its competitors? The main competitors of Aytu BioPharma include PMV Pharmaceuticals (PMVP), eXoZymes (EXOZ), IGM Biosciences (IGMS), Assertio (ASRT), ABVC BioPharma (ABVC), Unicycive Therapeutics (UNCY), VolitionRx (VNRX), Applied Therapeutics (APLT), Ovid Therapeutics (OVID), and Sutro Biopharma (STRO). These companies are all part of the "pharmaceutical products" industry. Aytu BioPharma vs. Its Competitors PMV Pharmaceuticals eXoZymes IGM Biosciences Assertio ABVC BioPharma Unicycive Therapeutics VolitionRx Applied Therapeutics Ovid Therapeutics Sutro Biopharma Aytu BioPharma (NASDAQ:AYTU) and PMV Pharmaceuticals (NASDAQ:PMVP) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation. Do analysts recommend AYTU or PMVP? Aytu BioPharma currently has a consensus target price of $10.00, suggesting a potential upside of 325.53%. PMV Pharmaceuticals has a consensus target price of $5.50, suggesting a potential upside of 292.86%. Given Aytu BioPharma's higher probable upside, research analysts plainly believe Aytu BioPharma is more favorable than PMV Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aytu BioPharma 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00PMV Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, AYTU or PMVP? Aytu BioPharma has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500. Comparatively, PMV Pharmaceuticals has a beta of 1.52, suggesting that its share price is 52% more volatile than the S&P 500. Is AYTU or PMVP more profitable? Aytu BioPharma has a net margin of 2.37% compared to PMV Pharmaceuticals' net margin of 0.00%. Aytu BioPharma's return on equity of 3.51% beat PMV Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Aytu BioPharma2.37% 3.51% 0.91% PMV Pharmaceuticals N/A -47.94%-43.82% Does the media favor AYTU or PMVP? In the previous week, Aytu BioPharma and Aytu BioPharma both had 1 articles in the media. PMV Pharmaceuticals' average media sentiment score of 1.88 beat Aytu BioPharma's score of 1.87 indicating that PMV Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Aytu BioPharma Very Positive PMV Pharmaceuticals Very Positive Which has better earnings and valuation, AYTU or PMVP? Aytu BioPharma has higher revenue and earnings than PMV Pharmaceuticals. Aytu BioPharma is trading at a lower price-to-earnings ratio than PMV Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAytu BioPharma$81M0.26-$15.84M-$0.72-3.26PMV PharmaceuticalsN/AN/A-$58.71M-$1.57-0.89 Do institutionals & insiders have more ownership in AYTU or PMVP? 33.5% of Aytu BioPharma shares are held by institutional investors. Comparatively, 90.2% of PMV Pharmaceuticals shares are held by institutional investors. 3.6% of Aytu BioPharma shares are held by company insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryAytu BioPharma beats PMV Pharmaceuticals on 7 of the 11 factors compared between the two stocks. Get Aytu BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AYTU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AYTU vs. The Competition Export to ExcelMetricAytu BioPharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.10M$3.07B$5.75B$9.76BDividend YieldN/A2.29%4.08%4.04%P/E RatioN/A20.7883.2726.60Price / Sales0.26386.53541.17113.73Price / CashN/A44.2237.4459.26Price / Book0.518.0710.556.58Net Income-$15.84M-$53.98M$3.27B$265.95M7 Day Performance6.82%-0.88%0.40%0.17%1 Month Performance-3.69%7.72%7.31%3.90%1 Year Performance-6.00%7.03%46.58%19.67% Aytu BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AYTUAytu BioPharma3.7067 of 5 stars$2.35+1.7%$10.00+325.5%-3.7%$21.10M$81M0.00160Positive NewsPMVPPMV Pharmaceuticals3.0951 of 5 stars$1.42-4.1%$5.50+287.3%-10.8%$78.43MN/A-0.9050High Trading VolumeEXOZeXoZymesN/A$9.70+4.1%N/AN/A$78.08M$70K0.0029Positive NewsIGMSIGM Biosciences4.5411 of 5 stars$1.27flat$5.50+333.1%N/A$76.57M$145.05M-1.41190Positive NewsASRTAssertio2.1425 of 5 stars$0.790.0%$2.38+202.3%-29.2%$75.62M$124.96M-1.7520Gap UpABVCABVC BioPharma0.3744 of 5 stars$2.93-8.7%N/A+313.7%$75.57M$510K-17.2330Gap UpUNCYUnicycive Therapeutics2.6096 of 5 stars$4.29+2.1%$60.00+1,298.6%+24.0%$74.18M$680K-1.049Analyst UpgradeVNRXVolitionRx2.4311 of 5 stars$0.69-0.3%$3.50+410.5%-2.9%$73.77M$1.32M-1.9080Analyst RevisionAPLTApplied Therapeutics3.9953 of 5 stars$0.51+0.5%$6.10+1,085.6%-92.2%$73.73M$460K-1.1430Positive NewsOVIDOvid Therapeutics4.1254 of 5 stars$1.14+10.7%$3.10+171.9%+13.3%$73.24M$570K-2.1560Analyst RevisionSTROSutro Biopharma4.1591 of 5 stars$0.84-2.5%$4.47+434.0%-81.2%$72.72M$62.04M-0.33240News Coverage Related Companies and Tools Related Companies PMV Pharmaceuticals Alternatives eXoZymes Alternatives IGM Biosciences Alternatives Assertio Alternatives ABVC BioPharma Alternatives Unicycive Therapeutics Alternatives VolitionRx Alternatives Applied Therapeutics Alternatives Ovid Therapeutics Alternatives Sutro Biopharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AYTU) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AYTU Stock Alerts